 |
|
Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Won Sohn, Hyun Woong Lee, Sangheun Lee, Jin Hong Lim, Min Woo Lee, Chan Hyuk Park, Seung Kew Yoon
Clin Mol Hepatol. 2021;27(1):157-174. Published online 2020 Nov 26 DOI: https://doi.org/10.3350/cmh.2020.0176
|
|
Citations to this article as recorded by
Statin use is associated with better
post‐operative
prognosis among patients with hepatitis B
virus‐related
hepatocellular carcinoma
Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin‐Ha Yoon, Beom Kyung Kim
European Journal of Clinical Investigation.2023;[Epub] CrossRef Updated epidemiology of gastrointestinal cancers in East Asia
Junjie Huang, Don Eliseo Lucero-Prisno, Lin Zhang, Wanghong Xu, Sunny H. Wong, Siew C. Ng, Martin C. S. Wong
Nature Reviews Gastroenterology & Hepatology.2023;[Epub] CrossRef Why Are Obese People Predisposed to Severe Disease in Viral Respiratory Infections?
Rafia Aziz, Afak Yusuf Sherwani, Saeed Al Mahri, Shuja Shafi Malik, Sameer Mohammad
Obesities.2023; 3(1): 46. CrossRef The higher body mass index is associated with a lower somatic mutation dependency in hepatocellular carcinoma
Nazanin Hosseinkhan, Zahra Narimani, Nastaran Masoudi-Khoram, Mohammad E. Khamseh
Informatics in Medicine Unlocked.2023; 37: 101187. CrossRef Body Mass Index and Cancer Risk: An Umbrella Review of Meta-Analyses of Observational Studies
Junhao Chen, Kaimin Ke, Zhenghuan Liu, Luchen Yang, Linchun Wang, Jing Zhou, Qiang Dong
Nutrition and Cancer.2023; : 1. CrossRef Anthropometric Indicators of Adiposity and Risk of Primary Liver Cancer: A Systematic Review and Dose-Response Meta-analysis
Lun-Jie Yan, Long-Shan Yang, Yu-Chuan Yan, Si-Yu Tan, Zi-Niu Ding, Hui Liu, Dong-Xu Wang, Zhao-Ru Dong, Tao Li
European Journal of Cancer.2023;[Epub] CrossRef Body mass index and serum alpha-fetoprotein level associated with PD1 expression and prognosis in patients with hepatocellular carcinoma
Lili Yang, Jili Wang, Linpeng Yao, Cheng Chen, Junhan Pan, Ling Peng, Feng Chen
Heliyon.2023; : e14460. CrossRef Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis
Yi-wen Shi, Jian-Gao Fan
Clinical and Molecular Hepatology.2023; 29(Suppl): S228. CrossRef Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL
Hye Won Lee, Soo Young Park, Yu Rim Lee, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
American Journal of Gastroenterology.2022; 117(2): 288. CrossRef NAFLD-driven HCC: Safety and efficacy of current and emerging treatment options
Friedrich Foerster, Simon Johannes Gairing, Lukas Müller, Peter Robert Galle
Journal of Hepatology.2022; 76(2): 446. CrossRef Changes in general and central fatness are associated with hepatocellular carcinoma: A Korean nationwide longitudinal study
Mi Na Kim, Kyungdo Han, Juhwan Yoo, Yeonjung Ha, Young Eun Chon, Ju Ho Lee, Seong Gyu Hwang
International Journal of Cancer.2022; 150(10): 1587. CrossRef Stratifying individuals into non-alcoholic fatty liver disease risk levels using time series machine learning models
Ofir Ben-Assuli, Arie Jacobi, Orit Goldman, Shani Shenhar-Tsarfaty, Ori Rogowski, David Zeltser, Itzhak Shapira, Shlomo Berliner, Shira Zelber-Sagi
Journal of Biomedical Informatics.2022; 126: 103986. CrossRef Study on the Application of Doxorubicin-Loaded Magnetic Nanodrugs in Targeted Therapy of Liver Cancer
Lei Wang, Liping Liang, Shuzhen Shi, Chao Wang, Fahd Abd Algalil
Applied Bionics and Biomechanics.2022; 2022: 1. CrossRef Insulin and cancer: a tangled web
Brooks P. Leitner, Stephan Siebel, Ngozi D. Akingbesote, Xinyi Zhang, Rachel J. Perry
Biochemical Journal.2022; 479(5): 583. CrossRef Effects of image-guided adaptive radiotherapy combined with hepatic artery chemoembolization in primary liver cancer patients
Yingchun Zhao, Changwang Zhang, Yongqian Zhang, Changwen Bo, Yonghui An, Na Li, Wenhua Ma, Changpeng Zou, Liping Zhao, Sujing Zhang
Clinics and Research in Hepatology and Gastroenterology.2022; 46(5): 101889. CrossRef Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis
Zijun Yan, Kun Yang, Xiang Tang, Yunfeng Bi, Yuzhen Ding, Mengyue Deng, Die Xia, Yunqi Zhao, Tong Chen, Fu Wang
Journal of Immunology Research.2022; 2022: 1. CrossRef Risk factors of liver malignancies in workers chronically exposed to ionizing radiation
Galina V. Zhuntova, Mariya V. Bannikova, Tamara V. Azizova
Ekologiya cheloveka (Human Ecology).2022; 29(5): 333. CrossRef Exercise in cancer prevention and anticancer therapy: Efficacy, molecular mechanisms and clinical information
Chuanmei Zhu, Hongbo Ma, Anqi He, Yi Li, Chengqi He, Yong Xia
Cancer Letters.2022; 544: 215814. CrossRef Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma
Pil Soo Sung
Clinical and Molecular Hepatology.2022; 28(3): 333. CrossRef The timing of adiposity and changes in the life course on the risk of cancer
Zhe Fang, Edward L. Giovannucci
Cancer and Metastasis Reviews.2022; 41(3): 471. CrossRef Association between metabolic syndrome, C-reactive protein, and the risk of primary liver cancer: a large prospective study
Mengmeng Song, Tong Liu, Hai Liu, Qi Zhang, Qingsong Zhang, Yiming Wang, Xiangming Ma, Liying Cao, Hanping Shi
BMC Cancer.2022;[Epub] CrossRef Response to Liao et al.
Byungyoon Yun, Jin-Ha Yoon, Beom Kyung Kim
American Journal of Gastroenterology.2022; 117(10): 1718. CrossRef Current cancer burden in China: epidemiology, etiology, and
prevention
Maomao Cao, He Li, Dianqin Sun, Siyi He, Xinxin Yan, Fan Yang, Shaoli Zhang, Changfa Xia, Lin Lei, Ji Peng, Wanqing Chen
Cancer Biology & Medicine.2022; 19(8): 1121. CrossRef Metabolic syndrome, obesity and cancer risk
Federico Belladelli, Francesco Montorsi, Alberto Martini
Current Opinion in Urology.2022; 32(6): 594. CrossRef Prognostic Impact of MAFLD Following Surgical Resection of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Nationwide Cohort Study
Byungyoon Yun, Sang Hoon Ahn, Juyeon Oh, Jin-Ha Yoon, Beom Kyung Kim
Cancers.2022; 14(20): 5002. CrossRef Gender Dimorphism in Hepatic Carcinogenesis-Related Gene Expression Associated with Obesity as a Low-Grade Chronic Inflammatory Disease
Andrea G. Izquierdo, Marcos C. Carreira, Gemma Rodriguez-Carnero, Raquel Perez-Lois, Luisa M. Seoane, Felipe F. Casanueva, Ana B. Crujeiras
International Journal of Molecular Sciences.2022; 23(23): 15002. CrossRef UEG position paper: Obesity and digestive health
Patrizia Burra, Marianna Arvanitakis, Jorge Amil Dias, Michael Bretthauer, Ana Dugic, Daniel Hartmann, Patrick Michl, Thomas Seufferlein, Joana Torres, Hans Törnblom, Monique E. van Leerdam, Shira Zelber‐Sagi, Andreea Botos
United European Gastroenterology Journal.2022; 10(10): 1199. CrossRef Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
Jae Seung Lee, Tae Seop Lim, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Hyun Woong Lee, Jung Il Lee, Ja Kyung Kim, In Kyung Min, Beom Kyung Kim
Diagnostics.2022; 13(1): 3. CrossRef Obesity as a Risk Factor for Different Cancers: Systematic Review
Abdelrahman Mohamed Ahmed Abukanna, Ziyad Mubarak S Alanazi, Amer Meshal H Alanazi, Atheer Humaidy S Alenazi, Abdulrahman Obaid A Alanazi, Khaloud Attaulla Alenezi, Gharam Mahmood Alsalmi
Clinical Cancer Investigation Journal.2022; 11(6): 45. CrossRef Metabolic disease as a risk of hepatocellular carcinoma
Naoshi Nishida
Clinical and Molecular Hepatology.2021; 27(1): 87. CrossRef Transcript levels of spindle and kinetochore-associated complex 1/3 as prognostic biomarkers correlated with immune infiltrates in hepatocellular carcinoma
De-Chen Yu, Xiang-Yi Chen, Xin Li, Hai-Yu Zhou, De-Quan Yu, Xiao-Lei Yu, Yi-Cun Hu, Rui-Hao Zhang, Xiao-Bo Zhang, Kun Zhang, Jiang-Dong An
Scientific Reports.2021;[Epub] CrossRef Obesity as a risk factor for diseases of the digestive system
Dmitry N. Andreev, Yury A. Kucheryavyy
Terapevticheskii arkhiv.2021; 93(8): 954. CrossRef Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1
Tae Suk Kim, Minjong Lee, Minji Park, Sae Yun Kim, Min Suk Shim, Chea Yeon Lee, Dae Hee Choi, Yuri Cho
International Journal of Molecular Sciences.2021; 22(18): 10027. CrossRef Lifestyle and Hepatocellular Carcinoma What Is the Evidence and Prevention Recommendations
Shira Zelber-Sagi, Mazen Noureddin, Oren Shibolet
Cancers.2021; 14(1): 103. CrossRef
|